Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Biomarker Stories

2014-04-17 23:07:50

New webinar will focus on scientific and process improvements that advance Rheumatoid Arthritis (RA) drug development. This live discussion takes place on Wednesday, May 7, 2014 at 10:00am EDT (15:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) April 17, 2014 Rheumatoid Arthritis (RA) is a complex and heterogeneous disease that has the potential to significantly impact morbidity, mortality and quality of life while also placing a substantial burden on healthcare systems globally. While...

2014-04-17 09:48:21

Findings may advance efforts to better manage the infection A team of scientists led by Johns Hopkins and Stanford University researchers has laid the groundwork for understanding how variations in immune responses to Lyme disease can contribute to the many different outcomes of this bacterial infection seen in individual patients. A report on the work appears online April 16 in PLOS One. "Physicians have recognized for many years that Lyme disease is not a uniform disease process and...

2014-04-15 08:31:06

Agreement supporting global development and manufacture of instrument to analyze protein and nucleic acid biomarkers continues multi-year relationship between Invetech and Biocartis. SAN DIEGO, April 15, 2014 /PRNewswire/ -- Invetech, a global leader in instrument development, custom automation, and contract manufacturing, and Biocartis, a diagnostics company focused on improving healthcare outcomes via the practice of personalized medicine, today announced a collaboration agreement...

2014-04-15 08:28:48

-- Octava(TM) Breast Cancer Tests Are Designed for Adjunctive Use with Screening Mammography to Help Identify False Positive and False Negative Results -- MIAMI, April 15, 2014 /PRNewswire/ -- Eventus Diagnostics, Inc. (EventusDx) today announced completion of a $2.72 million financing. The financing was led by a new family office private investor, and existing investors also participated. Proceeds of the financing will mostly be used to support the continued development and...

2014-04-15 08:28:24

DUBLIN, Apr. 15, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6zn3pr/global_microrna ) has announced the addition of the "Global MicroRNA Market Report" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA research funding....

2014-04-14 12:33:03

CALGARY, April 14, 2014 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that a poster authored by Bolton, et al was presented at the 8(th) Annual International Conference on Oncolytic Virus Therapeutics held in Oxford, UK. The poster, titled "Resistance to oncolytic reovirus is associated with high expression of Yes-Associated Protein (YAP-1) in head and neck cancer," covered preclinical research focused on identifying biomarkers...

2014-04-13 23:00:56

Metabolomics is one of the fastest growing markets in the scientific arena, finding its application in essential fields such as drug discovery, toxicology assessment, nutrigenomics and biomarker discovery. http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html (PRWEB) April 13, 2014 The report "Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and...

2014-04-11 16:21:36

DUBLIN, April 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/btp9ds/global_multiple) has announced the addition of the "Global Multiple Sclerosis (MS) Therapeutics Market Report" [http://www.researchandmarkets.com/research/btp9ds/global_multiple ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Multiple Sclerosis (MS) Therapeutics market to grow at...

2014-04-10 16:24:24

HILDEN, Germany and VIENNA, April 10, 2014 /PRNewswire/ -- - Reliable diagnostic tools under development for mutations of calreticulin (CALR) are expected to benefit patients with blood disorders known as myeloproliferative neoplasms - QIAGEN acquired exclusive worldwide license for CALR biomarker from CeMM Vienna, whose researchers recently published the discovery in the New England Journal of...

2014-04-09 23:25:06

Biochemical testing suggests a pair of proteins can find and monitor bladder cancer better than standard techniques. Raleigh, NC (PRWEB) April 09, 2014 A team of Egyptian biochemists say angiogenin and clusterin – two proteins vital to certain cellular processes – could make bladder cancer diagnosis more accurate and treatments more effective. Click here to read details on the study which has just been posted on the Cancer Monthly website. Researchers with the Faculty of...